GDF15 and Related Biomarkers
GDF15 and Related Biomarkers is a research topic within Rheumatology. Science Explorer counts 8.7k research works in it since 1954. 18.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of growth factors, particularly Growth-Differentiation Factor-15 (GDF-15) and Macrophage Inhibitory Cytokine-1 (MIC-1), in various physiological and pathological processes such as cardiovascular disease, obesity, metabolic homeostasis, neuroprotection, and inflammation. The papers also investigate the potential of these factors as biomarkers for different health conditions.
- Growth-Differentiation Factor-15
- TGF-ß Superfamily
- Macrophage Inhibitory Cytokine-1
- Mitochondrial-Derived Peptides
- Cardiovascular Disease
- Obesity
- Metabolic Homeostasis
- Neuroprotection
- Inflammation
- Biomarkers
- Research works
- 8.7k fractional, since 1954
- In the world top 10%
- 1.6k per year above
- Top-10% rate
- 18.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +52% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead GDF15 and Related Biomarkers research?
By volume, China and the United States publish the most (807 and 478 works in 2022–2025).
By volume, 2022–2025
- 1 China 807 works
- 2 United States 478 works
- 3 India 83 works
- 4 Japan 79 works
- 5 Germany 78 works
- 6 United Kingdom 73 works
- 7 Russia 61 works
- 8 Italy 57 works
- 9 South Korea 52 works
- 10 Spain 49 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead GDF15 and Related Biomarkers research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most GDF15 and Related Biomarkers research, followed by Capital Medical University and Shanghai Jiao Tong University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
- 2 Capital Medical UniversityChina 10 works
- 3 Shanghai Jiao Tong UniversityChina 9 works
- 4 Huazhong University of Science and TechnologyChina 9 works
- 5 Nanjing Medical UniversityChina 8 works
- 6 Sun Yat-sen UniversityChina 8 works
- 7 Central South UniversityChina 7 works
- 8 Harvard UniversityUnited States 7 works
- 9 Sichuan UniversityChina 7 works
- 10 Soochow UniversityChina 7 works
Who are the leading researchers in GDF15 and Related Biomarkers?
The most-cited researchers publishing on GDF15 and Related Biomarkers include Winfried März, Piotr Ponikowski and Naveed Sattar.
- 1 Winfried März Germany 5.2k citations
- 2 Piotr Ponikowski Poland 4.1k citations
- 3 Naveed Sattar United Kingdom 3.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is GDF15 and Related Biomarkers research done?
The largest centres of GDF15 and Related Biomarkers research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China).
Where is the best place to study GDF15 and Related Biomarkers?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Huazhong University of Science and Technology and Shanghai Jiao Tong University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 64.8 | 22.9% | 6.8× | 16 | +164.6% |
| 2 | Huazhong University of Science and TechnologyChina | 43.6 | 41.6% | 2.4× | 9 | +27.6% |
| 3 | Shanghai Jiao Tong UniversityChina | 36.4 | 30.6% | 1.7× | 9 | +88.5% |
| 4 | Capital Medical UniversityChina | 35.2 | 21.2% | 7.5× | 10 | -26.3% |
| 5 | Nanjing Medical UniversityChina | 30.9 | 23.6% | 6.7× | 8 | +49.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is GDF15 and Related Biomarkers research growing?
Output in 2018–2022 was 52% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are GDF15 and Related Biomarkers.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.